• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病、亨廷顿病和多发性硬化症患者黑质的定量蛋白质组学分析。

Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.

机构信息

Department of Molecular Neuroscience, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON M5T 1R8, Canada.

出版信息

Neurochem Res. 2012 Dec;37(12):2805-13. doi: 10.1007/s11064-012-0874-2. Epub 2012 Aug 28.

DOI:10.1007/s11064-012-0874-2
PMID:22926577
Abstract

The substantia nigra plays important roles in the brain function and is critical in the development of many diseases, particularly Parkinson's disease. Pathological changes of the substantia nigra have also been reported in other neurodegenerative diseases. Using a quantitative proteomic approach, we investigated protein expressions in the substantia nigra of Alzheimer's disease, Huntington's disease, and Multiple sclerosis. The expression level of one hundred and four proteins that were identified in at least three samples of each group were compared with the control group, with nineteen, twenty-two and thirteen proteins differentially expressed in Alzheimer's diseases, Huntington's disease and Multiple sclerosis respectively. The result indicates that the substantia nigra also undergoes functional adaption or damage in these diseases.

摘要

黑质在大脑功能中起着重要作用,是许多疾病(尤其是帕金森病)发展的关键。其他神经退行性疾病也报道了黑质的病理性变化。我们使用定量蛋白质组学方法研究了阿尔茨海默病、亨廷顿病和多发性硬化症患者黑质中的蛋白质表达。将每个组至少三个样本中的 104 种蛋白质的表达水平与对照组进行比较,分别在阿尔茨海默病、亨廷顿病和多发性硬化症中发现 19、22 和 13 种差异表达的蛋白质。结果表明,这些疾病也会导致黑质发生功能适应或损伤。

相似文献

1
Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.阿尔茨海默病、亨廷顿病和多发性硬化症患者黑质的定量蛋白质组学分析。
Neurochem Res. 2012 Dec;37(12):2805-13. doi: 10.1007/s11064-012-0874-2. Epub 2012 Aug 28.
2
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.亨廷顿舞蹈病患者黑质中大麻素受体的缺失
Neuroscience. 1993 Oct;56(3):523-7. doi: 10.1016/0306-4522(93)90352-g.
3
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes.
Neuroreport. 1995 May 9;6(7):1053-7. doi: 10.1097/00001756-199505090-00026.
4
Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.蛋白质组学与神经退行性疾病:诊断分析的进展。
Curr Protein Pept Sci. 2020;21(12):1174-1183. doi: 10.2174/1389203721666200511094222.
5
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.抗精神病药物在黑质中的结合:对正常、阿尔茨海默病、亨廷顿病和多发性硬化症患者大脑中高甲氧氯普胺结合的检查,以及其与迟发性运动障碍的关系。
Synapse. 2011 Feb;65(2):119-24. doi: 10.1002/syn.20825.
6
Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中基底神经节和黑质的免疫细胞化学研究。
Neuroscience. 1988 May;25(2):419-38. doi: 10.1016/0306-4522(88)90249-7.
7
Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.神经退行性疾病患者脑区中血管紧张素AT1和AT2受体亚型水平的改变。
Eur J Pharmacol. 1996 Feb 22;297(3):299-306. doi: 10.1016/0014-2999(95)00762-8.
8
Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.亨廷顿舞蹈病中基底神经节和黑质P物质水平的降低。
Brain Res. 1981 Mar 30;209(2):464-9. doi: 10.1016/0006-8993(81)90171-2.
9
Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.亨廷顿病、帕金森病和阿尔茨海默病患者基底神经节和黑质中P物质和甲硫氨酸脑啡肽的免疫细胞化学研究
J Neuropathol Exp Neurol. 1985 Jan;44(1):47-59. doi: 10.1097/00005072-198501000-00004.
10
A quantitative investigation of the substantia nigra in Huntington's disease.
Ann Neurol. 1989 Jul;26(1):13-9. doi: 10.1002/ana.410260103.

引用本文的文献

1
Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington's Disease Progression.阶段特异性血清蛋白质组学特征揭示亨廷顿舞蹈病进展中的早期生物标志物和分子途径。
Cells. 2025 Aug 4;14(15):1195. doi: 10.3390/cells14151195.
2
A Map of Transcriptomic Signatures of Different Brain Areas in Alzheimer's Disease.阿尔茨海默病不同脑区转录组特征图谱。
Int J Mol Sci. 2024 Oct 16;25(20):11117. doi: 10.3390/ijms252011117.
3
YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection.

本文引用的文献

1
Label-free quantitative proteomics analysis of cotton leaf response to nitric oxide.一氧化氮诱导棉花叶片蛋白质组的无标记定量分析
J Proteome Res. 2011 Dec 2;10(12):5416-32. doi: 10.1021/pr200671d. Epub 2011 Nov 15.
2
Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses.靶向敲除小鼠 Rad1 导致细胞 DNA 损伤反应缺陷。
Protein Cell. 2011 May;2(5):410-22. doi: 10.1007/s13238-011-1049-7. Epub 2011 Jun 2.
3
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.
YWHAH,一种 14-3-3 家族蛋白成员,以及 PSME2,蛋白酶体激活亚基 2,是日本脑炎病毒感染的关键宿主因子。
BMC Med Genomics. 2023 Jul 10;16(1):161. doi: 10.1186/s12920-023-01589-6.
4
Whole exome sequencing in dense families suggests genetic pleiotropy amongst Mendelian and complex neuropsychiatric syndromes.全外显子组测序在高度连锁家系中提示孟德尔和复杂神经精神综合征之间存在遗传表型多样性。
Sci Rep. 2022 Dec 7;12(1):21128. doi: 10.1038/s41598-022-25664-7.
5
Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.青少年型亨廷顿舞蹈病及其他多聚谷氨酰胺疾病:神经发育特征更新以及转录组学和蛋白质组学数据的比较生物信息学综述
Front Cell Dev Biol. 2021 Jul 1;9:642773. doi: 10.3389/fcell.2021.642773. eCollection 2021.
6
Quantitative Profiling of the Human Substantia Nigra Proteome from Laser-capture Microdissected FFPE Tissue.激光捕获微切割 FFPE 组织中人黑质蛋白质组的定量分析。
Mol Cell Proteomics. 2020 May;19(5):839-851. doi: 10.1074/mcp.RA119.001889. Epub 2020 Mar 4.
7
Connecting the Dots in the Neuroglobin-Protein Interaction Network of an Unstressed and Ferroptotic Cell Death Neuroblastoma Model.连接未应激和铁死亡细胞死亡神经母细胞瘤模型中神经球蛋白-蛋白相互作用网络中的点。
Cells. 2019 Aug 11;8(8):873. doi: 10.3390/cells8080873.
8
The role of the protein-RNA recognition code in neurodegeneration.蛋白质-RNA 识别码在神经退行性变中的作用。
Cell Mol Life Sci. 2019 Jun;76(11):2043-2058. doi: 10.1007/s00018-019-03096-3. Epub 2019 Apr 12.
9
Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.神经退行性疾病的蛋白质组学:人尸检脑组织分析。
J Neurochem. 2019 Nov;151(4):435-445. doi: 10.1111/jnc.14603. Epub 2018 Nov 22.
10
Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline.脑基因表达、DNA甲基化与晚年认知衰退中离体磁共振成像横向弛豫改变之间的关联
JAMA Neurol. 2017 Dec 1;74(12):1473-1480. doi: 10.1001/jamaneurol.2017.2807.
认知障碍和阿尔茨海默病中的能量代谢紊乱和神经元回路功能障碍。
Lancet Neurol. 2011 Feb;10(2):187-98. doi: 10.1016/S1474-4422(10)70277-5. Epub 2010 Dec 10.
4
Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease.帕金森病 MPTP 模型中小脑黑质和纹状体组织的蛋白质组分析。
Proteomics Clin Appl. 2007 Dec;1(12):1559-69. doi: 10.1002/prca.200700077. Epub 2007 Nov 16.
5
Multiple defects in energy metabolism in Alzheimer's disease.阿尔茨海默病中的能量代谢多重缺陷。
Curr Drug Targets. 2010 Oct;11(10):1193-206. doi: 10.2174/1389450111007011193.
6
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.肌酸激酶降低作为亨廷顿舞蹈病的中枢和外周生物标志物
Biochim Biophys Acta. 2010 Jul-Aug;1802(7-8):673-81. doi: 10.1016/j.bbadis.2010.05.001. Epub 2010 May 9.
7
Transcranial brain sonography findings predict disease progression in multiple sclerosis.经颅脑超声检查结果可预测多发性硬化症的疾病进展。
Neurology. 2009 Sep 29;73(13):1010-7. doi: 10.1212/WNL.0b013e3181b8a9f8. Epub 2009 Aug 5.
8
Multiple sclerosis: an immune or neurodegenerative disorder?多发性硬化症:一种免疫性疾病还是神经退行性疾病?
Annu Rev Neurosci. 2008;31:247-69. doi: 10.1146/annurev.neuro.30.051606.094313.
9
Experimental and computational approaches to quantitative proteomics: status quo and outlook.定量蛋白质组学的实验与计算方法:现状与展望
J Proteomics. 2008 Apr 30;71(1):19-33. doi: 10.1016/j.jprot.2007.12.001. Epub 2007 Dec 23.
10
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.阿尔茨海默病与后扣带回神经元中能量代谢基因的表达降低有关。
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4441-6. doi: 10.1073/pnas.0709259105. Epub 2008 Mar 10.